Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abdominal protrusion
acetylcholine
acromegaly
advances in neurology
adverse drug reaction
affective disorders
agitation
akathisia
algorithm
alpha methyldopa hydrazine
Alzheimer's disease
amantadine
amitriptyline
amphetamines
amphetamines, dyskinesia associated with
amygdala
anesthesia, general
anticholinergic drugs
anticholinergic drugs, side effects of
antidepressant
antihistamines
anxiety
apomorphine
aprazolam
arrhythmia, cardiac
aspartate aminotransferase
asterixis
atypical
autonomic dysfunction
axillary nerve
ballismus, bilateral
behavioral disorder
benzodiazepine
bladder dysfunction
bradykinesia
bromocriptine
Brueghel's syndrome
burning paresthesia
buspirone
carbidopa
CAT scan, emission
catechol-o-methyltransferase inhibitor
chest pain
chorea
clonazepam
clozapine
complications
confusion
controversies in neurology
Coombs test, positive
cough
delirium
delusion
dementia
deprenyl
depression
desipramine
diabetes mellitus
diarrhea
dopamine
dopamine agonist
drug abuse
drug addiction
drug holiday
drug induced neurologic disorders
drug interactions
drug withdrawal
dyskinesia
dyskinesia, buccal lingual facial
dyskinesia, drug induced
dyspnea
dystonia
dystonia, treatment of
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electroencephalogram, periodic complexes
electroencephalogram, triphasic delta waves
encephalopathy
entacapone
enzyme inhibition
enzyme, serum
epidemiology of neurology
excitotoxin
genetic neurologic disorders
globus pallidus, stimulation
groaning
hallucination
hallucination, visual
haloperidol
hemiballismus
hemidystonia
hunger
hyperthermia
iatrogenic neurologic disorders
imipramine
infusion pump
intellectual deficit
isoniazid
L-dopa
L-dopa, controlled release
L-dopa, delayed treatment in Parkinsonism
L-dopa, drug interactions with and side effects of
L-dopa, enteral infusion, continuous
L-dopa, plasma concentration
L-dopa, potentiators of
Lewy body
Lewy body disease, diffuse
livedo reticularis
liver function enzymes
locus ceruleus, lesion of
lorazepam
manic-depressive
melanoma, malignant
memory
memory, impairment of
mental status, abnormal
mitochondrial disease
monoamine oxidase inhibitors
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, treatment of
MRI
myoclonic jerks
myoclonus
myoclonus, sleep
nausea and vomiting
neuroendocrinology
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neurologic complications of, surgery
neurologic signs
neurologist
neuronal degeneration
neuropathology
nigrostriatal pathway
nortriptyline
olanzapine
ondansetron
oral contraceptives
oral contraceptives, choreiform movements with
orthostatic hypotension
pain
pallidotomy
panic attacks
papaverine
paranoia
paresthesias
Parkinson disease
Parkinson disease, complications, late
Parkinson disease, dementia with
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, drug holiday
Parkinson disease, dystonia with
Parkinson disease, early symptoms
Parkinson disease, fluctuations in
Parkinson disease, nonmotor problems of
Parkinson disease, on-off phenomena in
Parkinson disease, pathogenesis of
Parkinson disease, postencephalitic
Parkinson disease, sensory symptoms in
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinson disease, young onset
Parkinsonism plus syndrome
Parkinsonism syndrome
parsidol
patient information and support
pergolide
phenothiazine
phenothiazine, dyskinesia associated with
phobias
pramipexole
procyclidine
progressive supranuclear palsy
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
psychotic behavior
pyridoxine
quetiapine
raphe nuclei
reserpine and reserpine like drugs
reserpine treatment in movement disorder
respirations in CNS disease
respiratory dyskinesias
review article
rigidity
ritalin
ropinirole
selective serotonin reuptake inhibitors
serotonin antagonist
serum alanine aminotransferase
sinemet
single photon emission computed tomography
sleep pathology and physiology
start hesitation
stimulation, deep brain
substantia nigra
subthalamic nucleus
subthalamic nucleus deep brain stimulation
tardive dyskinesia
tolcapone
tonic foot response
torticollis
trazodone
treatment of neurologic disorder
tremor
tremor, thalamic stimulation for suppression of
tricyclic antidepressant
trigeminal neuralgia
vitamin, multiple
vocalizations
Showing articles 150 to 200 of 2466 << Previous Next >>

Advanced Interatrial Block and Ischemic Stroke
Neurol 87:352-356, ONeal, W.T.,et al, 2016

Outcomes with Edoxaban Versus Warfarin in Patients with Previous Cerebrovascular Events
Stroke 47:2075-2082, Rost, N.S.,et al, 2016

Primary Prevention of Stroke
JAMA 316:658-659, Steiger, N. & Cifu, A.S., 2016

Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke
Stroke 47:2380-2385, Yong, J.H.E.,et al, 2016

Stroke and Recurrent Haemorrhage Associated with Antithrombotic Treatment after Gastrointestinal Bleeding in Patients with Atrial Fibrillation: Nationwide Cohort Study
BMJ 351:h5876, h6104, Staerk, L.,et al, 2015

Cardiovascular Dysfunction in Multiple Sclerosis
Neurologist 20:108-114, Kaplan, T.B.,et al, 2015

Asymptomatic Atrial Fibrillation
JAMA 314:1911-1912, Freedman, S.B. & Lowres, N., 2015

Stroke Prevention in Atrial Fibrillation
JAMA 313:1950-1962, Lip, G.Y.H. & Lane, D.A., 2015

Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Current Status, Special Situations, and Unmet Needs
Lancet 386:303-310, Verheugt, F.W.A. & Granger, C.B., 2015

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
NEJM 373:823-833, Douketis,J.D.,et al, 2015

A 56-year-old Man with Cognitive Impairment and Difficulty Tying his Necktie
Neurol 85:e116-e122, Baker, J.M.,et al, 2015

Parkinsons Disease Beyond 20 Years
JNNP 86:849-855, Cilia, R.,et al, 2015

Sudden Cardiac Arrest in People with Epilepsy in the Community
Neurol 85:212-218, Lamberts, R.J.,et al, 2015

Reliability and Limitations of Automated Arrhythmia Detection in Telemetric Monitoring After Stroke
Stroke 46:560-563, Kurka, N.,et al, 2015

Rates of Ischemic Stroke During Warfarin Treatment for Atrial Fibrillation
Stroke 46:1120-1122, Tung, J.M.,et al, 2015

Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke
Stroke 46:936-941, Gladstone, D.J.,et al, 2015

Premature Ventricular Complexes on Screening Electrocardiogram and Risk of Ischemic Stroke
Stroke 46:1365-1367, Agarwal, S.K.,et al, 2015

Clinical Outcomes after Neurogenic Stress Induced Cardiomyopathy in Aneurysmal Sub-Arachnoid Hemorrhage: A Prospective Cohort Study
Clin Neurol Neurosurg 128:4-9, Kilbourn, K.J.,et al, 2015

Percutaneous Left Atrial Appendage Closure:Technical Aspects and Prevention of Periprocedural Complications with the Watchman Device
Workd J Cardiol 26:65-75, Mobius-Winkler,S.,et al, 2015

Intracranial Hemorrhage Mortality in Atrial Fibrillation Patients Treated with Dabigatran or Warfarin
Stroke 45:2286-2291, Alonso, A.,et al, 2014

Hormone Replacement Therapy and Adverse Outcomes in Women with Atrial Fibrillation
Stroke 45:3076-3079, Apostolakis, S.,et al, 2014

Association of Cerebral Microbleeds with Mortality in Stroke Patients Having Atrial Fibrillation
Neurol 83:1308-1315,1304, Song, T.J.,et al, 2014

Prolonged Cardiac Monitoring for Detection of Paroxysmal Atrial Fibrillation After Cerebral Ischemia
Stroke 45:1208-1214, Rabinstein, A.A., 2014

Rethinking Warfarin for Atrial Fibrillation
JAMA 311:1246, Zuccott, G & Pflomm, J.M., 2014

Factor Xa Inhibitors vs Warfarin for Preventing Stroke and Thromboembolism in Patients with Atrial Fibrillation
JAMA 311:1150-1151, Bruins Slot, K.M.H. & Berge, E., 2014

Brugada Syndrome in Spinal and Bulbar Muscular Atrophy
Neurol 82:1813-1821, Araki, A.,et al, 2014

Long-Term Effectivenss of Dopamine Agonists and Monoamine Oxidase B Inhibitors Compared with Levodopa as Initial Treatment for Parkinsons Disease (PD MED): A Large, Open-Label, Pragmatic Randomised Trial
Lancet 383: Doi: 10.1016/S0140-6736, PD MED Collaborative Group, 2014

Cryptogenic Stroke and Underlying Atrial Fibrillation
NEJM 370:2478-2486,2532, Sanna, T.,et al, 2014

Atrial Fibrillation in Patients with Cryptogenic Stroke
NEJM 370:2467-2477,2532, Gladstone, D.J.,et al, 2014

Cerebrovascular Events in 21 105 Patients with Atrial Fibrillation Randomized to Edoxaban Versus Warfarin
Stroke 45:2372-2378, Giugliano, R.P.,et al, 2014

Perioperative Atrial Fibrillation and the Long-Term Risk of Ischemic Stroke
JAMA 312:616-622, Gialdini, G.,et al, 2014

The Acquired Metabolic Disorders of the Nervous System, Ischemic-Hypoxic Encephalopathy
Adams & Victors Principles of Neurology Chp 40, pg 1133, Ropper, A.H.,et al, 2014

Oral Anticoagulants and the Risk of Intracranial Hemorrhage
JAMA 312:2562-2563, Vespa, P.M., 2014

Disturbances of Cerebrospinal Fluid, Including Hydrocephalus, Pseudotumor Cerebri, and Low-Pressure Syndromes, Parkinsonism and Midbrain Syndromes with Hydrocephalus and Shunting
Adams & Victors Principles of Neurology, Chp 30, pg 627, Ropper, A.H.,et al, 2014

Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Lyme Disease (Erythema Chronicum Migrans; Borreliosis
Adams & Victors Principles of Neurology, Chp 32, pg 728, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Parkinson Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1082, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Friedreich Ataxia
Adams & Victors Principles of Neurology, Chp 39, pg 1102, Ropper, A.H.,et al, 2014

Detection of Atrial Fibrillation After Ischemic Stroke or Transient Ischemic Attack
Stroke 45:520-526,355, Kishore, A.,et al, 2014

Preadmission Oral Anticoagulant Treatment and Clinical Outcome Among Patients Hospitalized with Acute Stroke and Atrial Fibrillation
Stroke 45:168-175, Johnsen, S.P.,et al, 2014

Effect of Citalopram on Agitation in Alzheimer Disease The CitAD Randomized Clinical Trial
JAMA 311:682-691, Porsteinsson, A.P.,et al, 2014

Summary of Evidence-Based Guideline Update: Prevention of Stroke in Nonvalvular Atrial Fibrillation
Neurol 82:716-724, Culebras, A.,et al, 2014

Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in Patients with Atrial Fibrillation: A Meta-Analysis of Randomised Trials
Lancet 383:955-962,931, Ruff, C.T.,et al, 2014

Evaluation of Cryptogenic Stroke with Advanced Diagnostic Techniques
Stroke 45:1186-1194, Bang, O.Y.,et al, 2014

Insertable Cardiac Event Recorder in Detection of Atrial Fibrillation After Cryptogenic Stroke
Stroke 44:2007-2009, Etgen, T.,et al, 2013

Clinicopathologic Conference, Oligoastrocytoma, Grade II with Temporal-Lobe Seizure and Ictal Asystole (Arrhythmogenic Epilepsy)
NEJM 368:2304-2312, Case 18-2013, 2013

Faxtor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients with Atrial Fibrillation
Stroke 44:e165-e167, Bruins, K.M.H., & Berge, E., 2013

Spectrum of Transient Visual Symptoms in a Transient Ischemic Attack Cohort
Stroke 44:3312-3317, Lavallee, P.C.,et al, 2013

Evaluation of Patients for Paroxysmal Atrial Fibrillation after Ischemic Stroke
Stroke 44:e168-e170, Sundararajan, K.,et al, 2013

Edoxaban Versus Warfarin in Patients with Atrial Fibrillation
NEJM 369:2093-2104, Giugliano, R.P.,et al, 2013

Occult Atrial Fibrillation in Cryptogenic Stroke
Stroke 44:1449-1452, Ritter, M.,et al, 2013



Showing articles 150 to 200 of 2466 << Previous Next >>